Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
Mirati Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Share |
Maximum Offering Price |
Fee Rate |
Amount of Registration Fee | |||||||
| Equity | Common Stock, $0.0001 par value per share, Inducement Plan | Rule 457(c) and Rule 457(h) | 773,757(2) | $42.605(3) | $32,965,917(3) | 0.0001476 | $4,865.77 | |||||||
| Total Offering Amounts | $32,965,917 | $4,865.77 | ||||||||||||
| Total Fee Offsets | — | |||||||||||||
| Net Fee Due | $4,865.77 | |||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s Common Stock (the “Common Stock”) that become issuable under the Mirati Therapeutics, Inc.’s Inducement Plan, as amended (the “Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction. |
| (2) | Represents new shares of Common Stock that were added to the shares authorized for issuance under the Plan pursuant to a second amendment to the Plan that was duly adopted and approved by the Compensation Committee of the Registrant’s board of directors on September 27, 2023. |
| (3) | This estimate is made pursuant to Rule 457(h)(1) and Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee. The proposed maximum offering price per share and maximum aggregate offering price are based upon the average of the high and low prices of the Common Stock on October 2, 2023, as reported on The Nasdaq Global Select Market. |